Inconsistent alignment with WHO TRS during WHO inspection – CAPA aligned to WHO standards



Published on 28/01/2026

Addressing Inconsistencies with WHO TRS: A Practical Playbook for CAPA Alignment

In an increasingly regulated environment, maintaining alignment with the World Health Organization’s Technical Report Series (WHO TRS) is critical for ensuring that pharmaceutical manufacturing practices meet rigorous GMP compliance standards. Inconsistencies identified during WHO inspections can lead to significant ramifications, including potential product recalls, regulatory sanctions, or even facility shutdowns. This playbook will equip professionals in manufacturing, quality control (QC), quality assurance (QA), engineering, and regulatory affairs (RA) with actionable steps to triage, investigate, and implement corrective and preventive actions (CAPA) in response to these findings.

By the end of this article, you will understand how to identify symptoms of non-compliance, conduct thorough investigations, develop robust CAPA strategies, and maintain inspection-ready documentation that satisfies WHO and relevant regulatory authority standards.

Symptoms/Signals on the Floor or in the Lab

Identifying the symptoms of inconsistent alignment with WHO TRS is the first step toward rectifying

the issue. These indicators may manifest in various areas:

  • Documentation Gaps: Missing or incomplete records that fail to demonstrate compliance with WHO requirements.
  • Increased Deviations: A sudden rise in deviation reports related to manufacturing or quality processes.
  • Product Quality Complaints: Feedback from customers indicating substandard product performance or safety issues.
  • Inspection Observations: Direct observations from internal audits or external inspections pointing to SOP violations.
  • Employee Feedback: Frontline employees expressing concerns regarding processes and compliance.

These signals should prompt immediate attention to investigate potential misalignments with WHO TRS.

Likely Causes

Understanding the root causes of inconsistencies can help in the development of targeted solutions. Here, we categorize potential causes based on the classic “6 Ms”: Materials, Method, Machine, Man, Measurement, and Environment.

Category Possible Causes Examples
Materials Quality of incoming materials Substandard raw materials not meeting specifications
Method Improper procedures Unapproved changes to manufacturing SOPs
Machine Equipment malfunction Calibration errors leading to inaccurate measurements
Man Lack of training or negligence Operators not compliant with GMP training protocols
Measurement Poor quality control testing Inaccurate equipment readings not flagged
Environment Uncontrolled manufacturing conditions Temperature or humidity beyond acceptable ranges
Pharma Tip:  Inadequate WHO GMP training during WHO inspection – WHO inspector expectations explained

Immediate Containment Actions (first 60 minutes)

Once a non-compliance issue is detected, swift containment actions are essential to mitigate potential risks and prevent the problem from escalating. Within the first 60 minutes:

  1. Assemble an Incident Response Team: Include representatives from QA, Manufacturing, and Engineering.
  2. Halt Affected Operations: Immediately stop any processes that may be affected.
  3. Implement Quarantine Procedures: Place affected products on hold and isolate materials or batches in question.
  4. Notify Regulatory Affairs: Inform RA stakeholders of the situation to prepare for potential regulatory dialogue.

Document all containment actions taken for transparency and future reference.

Investigation Workflow (data to collect + how to interpret)

Once containment is established, a structured investigation should occur. This workflow includes:

  1. Data Collection: Gather relevant documentation, including batch records, SOPs, training records, and quality control data.
  2. Observation Notes: Record details of the incident as soon as possible, capturing conditions and actions taken.
  3. Interviews: Speak with staff directly involved to gather insights about the issue and possible contributing factors.
  4. Trend Analysis: Review historical data for patterns that could indicate systemic issues.

Interpreting the collected data requires a thorough analysis of discrepancies compared to established WHO TRS guidelines. Collaboration among departments is often necessary to understand the context fully.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

Employing root cause analysis tools is vital in identifying the underlying issues leading to non-compliance. The following methodologies can be used depending on the complexity of the situation:

  • 5-Why Analysis: Use this method for straightforward problems where asking “why” leads to insights about the root causes, especially effective in cases of operational errors.
  • Fishbone Diagram: Ideal for complex issues involving multiple potential causes. Commonly used during team brainstorming sessions to visualize the relationship between causes and symptoms.
  • Fault Tree Analysis: Best suited for technical issues where an understanding of system failures is needed. This method helps in comprehensively analyzing potential faults against system designs.
Pharma Tip:  Documentation not aligned to WHO during internal gap assessment – CAPA aligned to WHO standards

Select the appropriate tool based on the nature of the incident to guide effective investigations.

CAPA Strategy (correction, corrective action, preventive action)

A robust CAPA strategy is essential to not only correct but also prevent recurring issues. This involves:

  1. Correction: Address the immediate problem with corrective measures; e.g., re-training staff, repairing equipment, or revising documentations.
  2. Corrective Action: Determine long-term corrective measures to eliminate the root cause. This could involve implementing new SOPs or enhancing material inspections.
  3. Preventive Action: Develop strategies that minimize the risk of future occurrences. This could involve routine audits of compliance with WHO TRS and continuous employee training programs.

Document every CAPA step diligently, as it showcases commitment to compliance and regulatory transparency.

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

Establishing an effective control strategy ensures ongoing compliance and quality consistency. This includes:

  • Statistical Process Control (SPC): Implement SPC techniques to monitor key process parameters continuously and establish control limits.
  • Regular Sampling: Conduct sampling at critical junctures and implement well-defined testing protocols to ensure product quality.
  • Monitoring Alarms: Use alarms or alerts for process deviations, ensuring real-time awareness of issues.
  • Verification Practices: Establish regular verification of processes and equipment to confirm compliance and functionality.

The combination of these elements will enhance quality monitoring and improve alignment with WHO standards.

Validation / Re-qualification / Change Control Impact (when needed)

The impact of findings on validation and change control processes should be assessed promptly. If non-compliance is identified, it may necessitate:

Related Reads

  • Re-qualification of Equipment: If issues were related to machine performance, undertake re-validation of involved equipment.
  • Review of Qualification Documents: Ensure prior validations are still applicable, updating them if there has been a change in process.
  • Change Control Review: Review any changes made in the operational processes to ensure compliance with established guidelines and assess their impact on overall quality.

Document changes and justifications thoroughly to maintain compliance with internal and regulatory standards.

Inspection Readiness: What Evidence to Show

Being ready for an inspection following internal findings can mitigate risks significantly. Essential documents to prepare include:

  • Records & Logs: Maintain meticulous records of all CAPA activities and investigations carried out.
  • Batch Documentation: Ensure batch records are complete, error-free, and reflect actual production processes.
  • Deviation Reports: Documented instances of deviation should convey how each was handled and any corrective actions taken.
Pharma Tip:  Documentation not aligned to WHO during remediation planning – gap remediation roadmap

These records demonstrate a culture of compliance and improvement, increasing confidence during inspections from regulatory authorities.

FAQs

What should I do if I find inconsistencies during an internal audit?

Immediately follow the containment actions outlined in this playbook and begin your investigation workflow.

How do I implement an effective CAPA strategy?

Ensure corrections are immediate, follow with long-term corrective actions, and develop preventive measures to minimize the risk of recurrence.

What tools are most effective in root cause analysis?

Choose based on the complexity of the issue—5-Why for simple problems, Fishbone for complex ones, and Fault Tree for technical failures.

How can I ensure my team is prepared for inspections?

Conduct regular training on SOPs, maintain clean documentation, and foster a culture of compliance awareness among all employees.

What are the key indicators of compliance with WHO TRS?

Document completeness, adherence to SOPs, quality of products, and lack of deviation reports are all key indicators of compliance.

Why is ongoing validation necessary?

Ongoing validation ensures that processes remain effective and comply with current regulations, particularly if changes in procedures occur.

How often should I review my control strategy?

Review your control strategy at least annually, or whenever significant changes to processes or equipment are implemented.

What documentation is essential during a WHO inspection?

Essential documentation includes batch records, logs, deviation reports, and evidence of CAPA implementations.

How do I enhance my manufacturing processes to meet WHO standards?

Focus on continuous improvement, employee training, strict adherence to documentation practices, and timely execution of CAPAs.

What is the role of quality assurance in maintaining compliance?

Quality assurance plays a critical role in ensuring operational compliance by validating processes, conducting audits, and providing training.

How can I assess employee compliance with GMP?

Conduct training assessments, audits of procedures performed, and monitor adherence to SOPs and other regulatory guidelines.

What preventive actions should I implement post-incident?

Establish rigorous training and monitoring programs designed to eliminate the recurrence of previously identified issues.